Several studies further suggest that fatty liver disease may facilitate CRC liver metastasis, potentially through the upregulation of fatty acid synthase (FASN) in the lipid-rich microenvironment, enhancing palmitate synthesis in CRC cells and thereby promoting hepatic metastatic potential [47,48]. The gene discussed is FASN; the disease is fatty liver disease.